medieval 发表于 2025-3-25 07:11:51

http://reply.papertrans.cn/1/48/4786/4786-21.png

expeditious 发表于 2025-3-25 09:16:40

http://reply.papertrans.cn/1/48/4786/4786-22.png

轻率的你 发表于 2025-3-25 12:49:59

http://reply.papertrans.cn/1/48/4786/4786-23.png

圆锥体 发表于 2025-3-25 17:38:49

Submitted on: 24 January 2025.
Revised on: 23 February 2025.
Accepted on: 09 April 2025.

___________________Cardiovascular Revascularization Medicine

Substance 发表于 2025-3-25 22:32:20

http://reply.papertrans.cn/1/48/4786/4786-25.png

liaison 发表于 2025-3-26 01:10:49

http://reply.papertrans.cn/1/48/4786/4786-26.png

脆弱吧 发表于 2025-3-26 06:06:21

Submitted on: 11 October 2001.
Revised on: 28 January 2002.
Accepted on: 09 February 2002.

___________________Cardiovascular Revascularization Medicine

tariff 发表于 2025-3-26 11:40:29

http://reply.papertrans.cn/1/48/4786/4786-28.png

Genetics 发表于 2025-3-26 14:13:36

http://reply.papertrans.cn/1/48/4786/4786-29.png

LAY 发表于 2025-3-26 16:51:01

http://reply.papertrans.cn/1/48/4786/4786-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Cardiovascular Revascularization Medicine 2024/2025影响因子:1.678 (CARDIOVASC REVASCULA) (1553-8389). (CARDIAC & CARD